Categories: News

Icario’s Annual Healthcare Innovation Summit Trailblaze 2022 Taking Place Aug. 10-11 in Minneapolis

Speakers Include Blue Zones Founder and Bestselling Author Dan Buettner and Healthcare Leaders From Aetna/CVS Health, Anthem, Medicaid Health Plans of America, UnitedHealthcare, Walmart Health

MINNEAPOLIS, June 22, 2022 (GLOBE NEWSWIRE) — Icario, the healthcare industry’s largest health action company, today announced registration is now open for Trailblaze 2022, the company’s annual healthcare innovation summit. This year’s event will take place on Aug. 10 and 11 at the Nicollet Island Pavilion in Minneapolis.

What: Trailblaze 2022

Who: New York Times bestselling author and Blue Zones founder Dan Buettner will deliver an inspirational keynote. Other speakers include leaders from Anthem, Medicaid Health Plans of America, UnitedHealthcare, Social Innovation Ventures, CVS Health | Aetna, Walmart Health, Vail Place, and Icario.

When: Aug. 10 and 11

Where: Nicollet Island Pavilion, 40 Power Street, Minneapolis, MN.

Event Info: Trailblaze 2022 is designed to energize, inspire and provide insights into the fast-moving healthcare industry. Attendees will collaborate and learn alongside some of the brightest minds in healthcare on the hottest topics and trends and leave with actionable insights to share with their teams. Registration is available here. A full agenda can be found at https://trailblazesummit.com.

About Icario
Icario is the leading health action company focused on connecting people to health. Icario uses pioneering behavioral research, data science, and our adaptive multi-channel platform to deliver personalization at scale for the most trusted healthcare organizations in all 50 states, including eight of the ten largest health plans. Learn more at www.icariohealth.com.

BOCA Communications for Icario
icario@bocacommunications.com

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

20 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago